Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 22, 2024

BUY
$144.38 - $157.78 $53,420 - $58,378
370 New
370 $54,000
Q2 2023

Aug 07, 2023

BUY
$154.35 - $166.11 $44,607 - $48,005
289 Added 2.23%
13,230 $2.19 Million
Q1 2023

Apr 27, 2023

BUY
$151.05 - $180.26 $71,144 - $84,902
471 Added 3.78%
12,941 $2.01 Million
Q4 2022

Feb 01, 2023

BUY
$160.2 - $179.79 $26,272 - $29,485
164 Added 1.33%
12,470 $2.2 Million
Q3 2022

Feb 01, 2023

BUY
$161.33 - $179.52 $125,030 - $139,128
775 Added 6.72%
12,306 $2.01 Million
Q2 2022

Aug 04, 2022

BUY
$168.19 - $186.01 $86,449 - $95,609
514 Added 4.67%
11,531 $2.05 Million
Q1 2022

May 09, 2022

BUY
$158.14 - $179.59 $54,716 - $62,138
346 Added 3.24%
11,017 $1.95 Million
Q4 2021

Feb 10, 2022

BUY
$155.93 - $173.01 $31,186 - $34,602
200 Added 1.91%
10,671 $1.83 Million
Q3 2021

Feb 10, 2022

BUY
$161.5 - $179.47 $201,229 - $223,619
1,246 Added 13.51%
10,471 $1.69 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $204,931 - $219,824
1,285 Added 16.18%
9,225 $1.52 Million
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $86,943 - $96,832
568 Added 7.7%
7,940 $1.31 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $2,330 - $2,675
-17 Reduced 0.23%
7,372 $1.16 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $9,405 - $10,306
67 Added 0.92%
7,389 $1.09 Million
Q2 2020

Aug 20, 2020

BUY
$128.81 - $155.51 $188,320 - $227,355
1,462 Added 24.95%
7,322 $1.03 Million
Q4 2019

Feb 10, 2020

BUY
$127.5 - $146.44 $41,947 - $48,178
329 Added 5.95%
5,860 $855,000
Q3 2019

Nov 21, 2019

BUY
$126.95 - $142.14 $53,445 - $59,840
421 Added 8.24%
5,531 $716,000
Q2 2019

Jul 11, 2019

BUY
$131.15 - $144.24 $29,639 - $32,598
226 Added 4.63%
5,110 $712,000
Q1 2019

May 01, 2019

BUY
$125.72 - $139.79 $59,088 - $65,701
470 Added 10.65%
4,884 $683,000
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $542,215 - $652,565
4,414 New
4,414 $570,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $401B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cypress Capital, LLC Portfolio

Follow Cypress Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital, LLC with notifications on news.